dipyridamole has been researched along with Essential Polyarteritis in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corbeel, L | 1 |
Gewillig, M | 1 |
Baeten, E | 1 |
Casteels-Van Daele, M | 1 |
Eggermont, E | 1 |
Friedman, A | 1 |
Kincaid-Smith, P | 1 |
2 other studies available for dipyridamole and Essential Polyarteritis
Article | Year |
---|---|
Carotid and coronary artery involvement in infantile periarteritis nodosa possibly induced by Coxsackie B4 infection. Favourable course under corticosteroid treatment.
Topics: Aspirin; Carotid Artery Diseases; Coronary Disease; Coxsackievirus Infections; Dexamethasone; Dipyri | 1987 |
Arteritis with impaired renal function.
Topics: Adult; Aged; Anticoagulants; Azathioprine; Biopsy; Cyclophosphamide; Dipyridamole; Drug Therapy, Com | 1973 |